Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study aims to compare the steady state pharmacokinetics of stavudine, lamivudine, and
nevirapine in HIV positive Ugandan patients taking Triomune 40 with the pharmacokinetics of
the originator products known as Viramune, Epivir and Zerit 40.